SIOX Share Price Performance
US$0
0.00 (0.00%)
Sorry, there is currently no price data for this company.
Can Sio Gene Therapies (NASDAQ:SIOX) Afford To Invest In Growth?
Oct 19
Sio Gene Therapies Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
SIOX Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
Sio Gene Therapies Inc. Key Details
About SIOX
- Founded
- 2014
- Employees
- 12
- CEO
- WebsiteView website
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical School to develop and commercialize gene therapy product candidates, including AXO-AAV-GM1 and AXO-AAV-GM. The company was formerly known as Axovant Gene Therapies Ltd. and changed its name to Sio Gene Therapies, Inc. in November 2020. Sio Gene Therapies, Inc. was incorporated in 2014 and is based in New York, New York.
